These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6814639)

  • 1. Bilateral abdominal lipohypertrophy after continuous subcutaneous infusion of insulin.
    Mier A; Weerakoon J; Dandona P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6354):1539. PubMed ID: 6814639
    [No Abstract]   [Full Text] [Related]  

  • 2. [Local lipohypertrophy in insulin treatment].
    Herold DA; Albrecht G
    Hautarzt; 1993 Jan; 44(1):40-2. PubMed ID: 8436508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
    Hernar I; Haltbakk J; Broström A
    J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Wallymahmed ME; Littler P; Clegg C; Haqqani MT; Macfarlane IA
    Postgrad Med J; 2004 Dec; 80(950):732-3. PubMed ID: 15579616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.
    Karlin AW; Ly TT; Pyle L; Forlenza GP; Messer L; Wadwa RP; DeSalvo DJ; Payne SL; Hanes S; Clinton P; Maahs DM; Buckingham B
    Diabetes Technol Ther; 2016 Jul; 18(7):429-35. PubMed ID: 27227290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipohypertrophy--a complication of insulin injections.
    de Villiers FP
    S Afr Med J; 2005 Nov; 95(11):858-9. PubMed ID: 16344882
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin injection sites in diabetes--a neglected area?
    Young RJ; Steel JM; Frier BM; Duncan LJ
    Br Med J (Clin Res Ed); 1981 Aug; 283(6287):349. PubMed ID: 6788324
    [No Abstract]   [Full Text] [Related]  

  • 10. Pictures in medicine 12. Insulin-induced lipohypertrophy.
    Iqbal P
    Br J Hosp Med; 1996 Feb 7-20; 55(3):138. PubMed ID: 8907880
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 12. Aprotinin induced lipohypertrophy and glomerulonephritis in an insulin dependent diabetic.
    Dandona P; Mier A; Boag F; Chappell M; Beckett AG
    Diabetes Res; 1985 Jul; 2(4):213-6. PubMed ID: 2417774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine insulin therapy and lipohypertrophy.
    Mahadevan S; Bhadada SK; Velayutham P; Bhansali A
    Arch Dis Child; 2004 Jul; 89(7):624. PubMed ID: 15210491
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic ketoacidosis associated with outpatient treatment using continuous subcutaneous insulin infusion.
    Boulton AJ; Knight G; Drury J; Ward JD
    Postgrad Med J; 1983 Jul; 59(693):438-9. PubMed ID: 6413960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local skin reaction caused by the plastic catheter tubing of the continuous subcutaneous insulin infusion system.
    Nguyen TV; Burnett JW
    Cutis; 1988 May; 41(5):355-6. PubMed ID: 3371087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor glycaemic control caused by insulin induced lipohypertrophy.
    Chowdhury TA; Escudier V
    BMJ; 2003 Aug; 327(7411):383-4. PubMed ID: 12919996
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrasound detection of insulin-induced lipohypertrophy in Type 1 and Type 2 diabetes.
    Kapeluto JE; Paty BW; Chang SD; Meneilly GS
    Diabet Med; 2018 Oct; 35(10):1383-1390. PubMed ID: 29908078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: deaths among patients using continuous subcutaneous insulin infusion pumps--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Nov; 31(46):625-6. PubMed ID: 6817073
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous subcutaneous insulin-infusion pumps.
    Clark JD; Wheatley T; Edwards OM
    N Engl J Med; 1984 Oct; 311(16):1052-3. PubMed ID: 6482914
    [No Abstract]   [Full Text] [Related]  

  • 20. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia.
    Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.